JPH06107555A - Oriental bezoar microcapsule and preparation thereof - Google Patents

Oriental bezoar microcapsule and preparation thereof

Info

Publication number
JPH06107555A
JPH06107555A JP5112347A JP11234793A JPH06107555A JP H06107555 A JPH06107555 A JP H06107555A JP 5112347 A JP5112347 A JP 5112347A JP 11234793 A JP11234793 A JP 11234793A JP H06107555 A JPH06107555 A JP H06107555A
Authority
JP
Japan
Prior art keywords
yellow
spray
added
gum
beef
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5112347A
Other languages
Japanese (ja)
Inventor
Chong-Kook Kim
鐘國 金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019920006424A external-priority patent/KR930021196A/en
Application filed by Individual filed Critical Individual
Publication of JPH06107555A publication Critical patent/JPH06107555A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: To provide a Goou-Seishin microcapsule which is convenient to carry and take, is easy to take for its capability of concealing the strong taste of crude drug extract, extremely rapidly exhibits effects and is preservable for a long period. CONSTITUTION: The Goou-Seishin microcapsule is obtd. by finely pulverizing the crude drugs which are the respective components of Goou-Seishinngan (a Chinese herb medicine: Goou is Bezoar Bovis, Seishinngan is the pill or powder formulated to provide mental stability by eliminating the cause for palpitations, anxiety at the time of sleeping, etc.), suspending the powder in water and ethanol or precipitating the powder with the water and ethanol and mixing the same or joining the respective components and precipitating the mixture with the water and ethanol, adding suitable materials to be filmed, dissolution assistants, aromatic sugar and other necessary additives to the mixture, then instantaneously drying the mixture by utilizing a spray drier. Such a difficulty that the thickening is needed during production stages does not exist and the mass production is easy, unlike the case of liquid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、牛黄清心マイクロカプ
セル及びその製造方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to beef yellow Qingshin microcapsules and a method for producing the same.

【0002】[0002]

【従来の技術】牛黄清心丸は昔から脳卒中、動脈硬化
症、高血圧、心悸昂進、呼吸困難、精神不安、狭心症、
急慢性驚風、自立神経失調症、人事不明等に使用されて
きた代表的漢方薬で時々丸剤の形態で使用されてき、現
在一部の製薬会社では液体の形態を開発して液剤の形態
で市販されている。
2. Description of the Related Art Ushio Hyoseishinmaru has long been known for stroke, arteriosclerosis, hypertension, heart palpitations, dyspnea, anxiety, angina,
It is a typical herbal medicine that has been used for acute chronic astonishment, autonomic imbalance, unknown human resources, etc., and is sometimes used in the form of pills.Currently, some pharmaceutical companies have developed a liquid form and used it in the form of a liquid drug. It is commercially available.

【0003】牛黄清心丸は、1985年度薬効再評価に
よれば山薬 263mg、甘草 188mg、人参 9
4mg、蒲黄 94mg、神曲 94mg、大豆皇巻
66mg、桂皮 66mg、阿膠 66mg、芍薬 5
6mg、麦門冬 56mg、黄ごん 56mg、当帰
56mg、防風 56mg、白朮 56mg、柴胡47
mg、桔梗 47mg、杏仁 47mg、茯苓 47m
g、川きゅう 47mg、牛黄 45mg、羚羊角 3
8mg、麝香 38mg、龍脳 38mg、白れん 2
8mg、及び乾薑 28mg等を1丸中に含有してお
り、この処方は牛黄清心丸の処方に従って又はその各成
分の含量に従って若干の差異があり得る。
According to the 1985 re-evaluation of drug efficacy, Ushio Hyoshinshin Maru has 263 mg of Yamayaku, 188 mg of licorice, and 9 ginseng.
4mg, Guangxi 94mg, Shinkyoku 94mg, Soybean Imperial Roll
66mg, cinnamon 66mg, Ag 66mg, peony
6 mg, Bakumon winter 56 mg, yellow rice 56 mg, toki
56 mg, windproof 56 mg, white syrup 56 mg, sago 47
mg, Chinese bellflower 47mg, Apricot kernel 47mg, Furei 47m
g, river cucumber 47 mg, beef yellow 45 mg, goose horn 3
8 mg, musk 38 mg, Borneolum 38 mg, white brick 2
One round contains 8 mg, ginseng 28 mg and the like, and this formulation may have some differences according to the beef Huangseishinmaru's formulation or the content of each component thereof.

【0004】[0004]

【外1】 牛黄清心丸は救急常備薬や予備薬として使用するが、丸
剤の場合救急患者に服用が不便であり、特に幼児や小児
には服用が困難で薬効が遅く現れる問題点があるので、
このような問題点を解決するため液剤(大韓民国特許9
0−2845)等種々の形態の製剤が開発されている
が、液剤の場合携帯が不便であり生薬抽出物の強い味の
ため服用するのが困難であり、また製造工程中抽出液を
濃縮させねばならない困難のため大量生産が難しい。
[Outer 1] Ushihokushinshinmaru is used as an emergency medicine or a reserve medicine, but in the case of pills, it is inconvenient for emergency patients to take, and especially for infants and children, it is difficult to take and the drug effect appears late, so there is a problem.
In order to solve such problems, liquid medicine (Korean Patent 9
0-2845) and other various forms of preparations have been developed, but it is difficult to take liquid medicines due to the inconvenience and strong taste of the crude drug extract, and it is also necessary to concentrate the extract during the manufacturing process. Mass production is difficult because of the difficulties that must be met.

【0005】[0005]

【発明が解決しようとする課題】本発明者は長い間の研
究の結果、難溶性薬物の溶解度増加の一方法として固形
エリキシル剤の製造原理を牛黄清心丸に適用すれば携帯
及び服用が便利で、特に生薬抽出物の強い味を隠蔽する
ことができて服用しやすくまた極めて迅速な薬効が現れ
るのみでなく、製造工程中濃縮しなければならない困難
がないので大量生産が容易である事実を発見して、本発
明を完成した。従って、代々相次いできた代表的漢方薬
である牛黄清心丸を更に一歩科学化して、携帯及び服用
が便利で特に生薬抽出物の強い味が隠蔽されて服用し易
く、極めて迅速に薬効が現れるのみでなく、製造工程中
濃縮過程がないので迅速に大量生産を成し得る新しい製
剤である牛黄清心丸マイクロカプセル及びその製造方法
を提供するのが本発明の目的である。
As a result of a long-term study, the present inventor has found that applying the manufacturing principle of a solid elixir to Gyuhokuseishinmaru as a method for increasing the solubility of a poorly soluble drug is convenient for carrying and taking. , Found that not only the strong taste of crude drug extract can be masked, it is easy to take and the drug effect is very quick, and also mass production is easy because there is no difficulty to concentrate during the manufacturing process. Then, the present invention was completed. Therefore, the traditional Chinese herbs, which have been in succession for generations, have been further stepped up to science, and are convenient to carry and to take, especially because the strong taste of the crude drug extract is hidden and easy to take, and the drug effect appears very quickly. In addition, it is an object of the present invention to provide a new preparation of beef huangshinshingan microcapsules and a method for producing the same, which is a new preparation that can be rapidly mass-produced because there is no concentration step during the manufacturing process.

【0006】[0006]

【課題を解決するための手段】本発明の原理は次の通り
である。上記牛黄清心丸の各成分である生薬を水及びエ
タノールで沈出すれば、生薬成分が水やエタノール又は
その混合溶媒に溶解抽出され、この抽出液に、水には親
和性があるがエタノールには溶けない第3の物質(被膜
物質)を添加して瞬間的に乾燥させれば初期蒸発によっ
て表面に被膜物質の濃度が増加するようになって被膜物
質層を形成するようになる。この被膜物質層は選択膜と
して作用して、水は拡散によって通過して蒸発しエタノ
ール及び生薬成分はこの膜を通過できないので、内部に
残留するようになり被膜物質によって包まれたマイクロ
カプセルが生成される。このような現象は瞬間乾燥方法
で効率的に起こるので噴霧乾燥器の使用が必須的であ
る。このときこのマイクロカプセルにはエタノールに溶
ける生薬成分はそのままエタノール層に溶けており、水
は拡散によって膜を通過して蒸発するので、水に溶ける
生薬成分はエタノール層に懸濁されているか膜の内側表
面に存在するようになる。
The principle of the present invention is as follows. If the crude drug, which is each component of the above-mentioned beef yellow Seishin-maru, is precipitated with water and ethanol, the crude drug component is dissolved and extracted in water or ethanol or a mixed solvent thereof, and this extract has an affinity for water but ethanol. If an insoluble third substance (coating substance) is added and instantaneously dried, the concentration of the coating substance increases on the surface due to the initial evaporation and a coating substance layer is formed. This coating material layer acts as a selective membrane, water passes through diffusion and evaporates, and ethanol and herbal ingredients cannot pass through this membrane, so that it remains inside and microcapsules encapsulated by the coating material are formed. To be done. Since such a phenomenon occurs efficiently in the instant drying method, it is essential to use a spray dryer. At this time, the crude drug component that is soluble in ethanol is dissolved in the ethanol layer as it is in this microcapsule, and water passes through the membrane by diffusion and evaporates, so the crude drug component that is soluble in water is suspended in the ethanol layer. Be present on the inner surface.

【0007】本発明の製造方法は、上記牛黄清心丸の各
成分である生薬をそのまま微細粉末化して水及びエタノ
ールに懸濁するか、水及びエタノールで沈出してこれを
混合するか、又はこれらの各成分を合わせて水及びエタ
ノールで抽出して適当な被膜物質、界面活性剤、溶解補
助剤、香味剤等その他必要な添加剤を添加した後、噴霧
乾燥器を利用して瞬間的に乾燥させて牛黄清心マイクロ
カプセルを製造するのである。
[0007] In the production method of the present invention, the crude drug which is each component of the above-mentioned Beef Huangseishinmaru is finely powdered as it is and suspended in water and ethanol, or it is precipitated with water and ethanol and mixed, or Each component of the above is combined and extracted with water and ethanol, and after adding appropriate coating substances, surfactants, solubilizers, flavoring agents and other necessary additives, it is dried instantaneously using a spray dryer. Then, the beef yellow Qingshin microcapsules are manufactured.

【0008】本発明に使用する被膜物質としては、デキ
ストリン、可溶性澱粉、アラビアゴム、ゼラチン、アル
ギン酸ナトリウム、トラガカンタゴム、ザンタンゴム、
グアゴム及びその他エタノールと水の混合溶媒ではある
程度溶解され、純粋エタノールでは溶解されない物質等
を単独又は混合して使用する。
The coating substance used in the present invention includes dextrin, soluble starch, gum arabic, gelatin, sodium alginate, tragacanta gum, xanthan gum,
Guar gum and other substances that are dissolved to some extent in a mixed solvent of ethanol and water and are not dissolved in pure ethanol are used alone or in combination.

【0009】本発明に使用される添加剤としては、懸濁
液を均一にするため使用するラウリル硫酸ナトリウム、
又はポリオキシエチレン系列の界面活性剤ないしポリオ
キシエチレン−ポリオキシプロピレン付加化合物系列の
界面活性剤等のような界面活性剤、噴霧乾燥の際生成物
が噴霧乾燥器内の器壁に付着せず、生成物が水分に対す
る防湿性を持たせるため使用する二酸化珪素のような安
定剤、レンジ香のように製剤に使用し得る香味剤等を使
用することができる。また、被膜の物性を調節するため
カルボキシメチルセルロースやトリウム、カルボキシメ
チルセルロースカルシウム、結晶セルロース、ヒドロキ
シエチルセルロース、ヒドロキシプロピルセルロース、
メチルセルロース、ポリビニルアルコール、ポリビニル
ピロリドン等のような高分子化合物及び白糖、マンニト
ール、ソルビトール、果糖、乳糖、グルコース、ガラク
トース等のような糖類を使用することもできる。高分子
物質と糖類は混合して使用することにより被膜の物性を
調節することもできる。
The additives used in the present invention include sodium lauryl sulfate used to make the suspension uniform,
Or a surfactant such as a polyoxyethylene series surfactant or a polyoxyethylene-polyoxypropylene addition compound series surfactant, etc., and the product does not adhere to the vessel wall in the spray dryer during spray drying. It is possible to use a stabilizer such as silicon dioxide, which is used for the product to have a moisture-proof property against moisture, and a flavoring agent which can be used in the preparation such as ranger fragrance. In addition, in order to control the physical properties of the coating, carboxymethyl cellulose and thorium, carboxymethyl cellulose calcium, crystalline cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose,
It is also possible to use polymer compounds such as methyl cellulose, polyvinyl alcohol, polyvinyl pyrrolidone and the like and sugars such as sucrose, mannitol, sorbitol, fructose, lactose, glucose and galactose. It is also possible to control the physical properties of the coating by using a polymer substance and a saccharide as a mixture.

【0010】牛黄清心丸の各成分は全体の成分をマイク
ロカプセル形態にすることもでき、牛黄清心丸の成分中
水に溶解し難い成分など、例えば、牛黄、麝香又は羚羊
角等のような物質は残りの成分をマイクロカプセル化し
た後にこれら生薬成分の微細粉末をマイクロカプセルと
混合して製造することもできる。
[0010] Each component of Gyuhuangseishinmaru can be made into a microcapsule form as a whole, and the ingredients of gyuhuangshinshinmaru are those which are difficult to dissolve in water, for example, substances such as beef huang, musk or wort horn. It can also be manufactured by microencapsulating the remaining ingredients and then mixing fine powders of these crude drug ingredients with the microcapsules.

【0011】このように製造した本発明の牛黄清心マイ
クロカプセルは水と接触すればほとんど瞬間的に溶解さ
れて内容物である牛黄清心丸の生薬成分が溶解されるか
懸濁されるので、服用とほとんど同じ瞬間に溶解されて
液剤タイプの牛黄清心丸のように迅速な薬効を現す長所
があり、また長期保存が可能で携帯が簡便な長所があ
る。
The thus-produced beef yellow Qingshin microcapsules of the present invention are almost instantaneously dissolved upon contact with water to dissolve or suspend the herbal medicine component of the contents, Beef yellow Qingshin gan, so that it can be taken. It has the advantages of being dissolved at almost the same moment and exhibiting a rapid drug effect like the liquid type Ushi Huangshinshin-maru, and it has the advantage of being able to be stored for a long time and easy to carry.

【0012】このように製造された牛黄清心マイクロカ
プセルは、そのままの散剤形態で包装するか、又は通常
の賦形剤及び添加剤等を添加し通常の方法で錠剤、カプ
セル剤、細粒剤等に剤形化することもできる。
The thus-produced beef yellow cypress heart microcapsules are packed in the powder form as it is, or tablets, capsules, fine granules and the like are added in the usual manner by adding usual excipients and additives. It can also be made into a dosage form.

【0013】次の実施例で本発明を具体化する。The invention is embodied in the following examples.

【0014】[0014]

【実施例】以下、本発明の実施例及びその比較例によっ
て本発明を更に具体的に説明するが、本発明はこれらの
実施例に限定されるものではない。
The present invention will be described in more detail below with reference to examples of the present invention and comparative examples thereof, but the present invention is not limited to these examples.

【0015】実施例1 山薬 2630mg、甘草 1880mg、人参 94
0mg、蒲黄 940mg、神曲 940mg、大豆皇
巻 660mg、桂皮 660mg、阿膠 660m
g、芍薬 560mg、麦門冬 560mg、黄ごん
560mg、当帰560mg、防風 560mg、白朮
560mg、柴胡 470mg、桔梗470mg、杏
仁 470mg、茯苓 470mg、川きゅう 470
mg、羚羊角 380mg、龍脳 380mg、白れん
280mg、及び乾薑 280mgの23種の生薬を
粉砕して合わせた後、50%(v/v)エタノール10
0mlで加熱循環式抽出器で2時間抽出、濾過する。こ
の濾液にデキストリン30gを入れて溶かし、予め微細
粉末化した牛黄450mg及び麝香380mgを懸濁し
た後噴霧法でマイクロカプセルを製造する。この製品は
エタノールを30重量%含有し6.6gが1丸該当量で
ある。
Example 1 Mountain herb 2630 mg, licorice 1880 mg, carrot 94
0mg, Guangxi 940mg, Shinkyoku 940mg, Soybean Emperor Roll 660mg, Cinnamon 660mg, Aguri 660m
g, peony 560mg, barley winter 560mg, yellow rice
560mg, Toki 560mg, Windbreak 560mg, Shiroshu 560mg, Saiko 470mg, Kikyo 470mg, Apricot kernel 470mg, Furei 470mg, Kawakyu 470
50% (v / v) ethanol 10 after crushing and combining 23 kinds of herbal medicines of mg, ram sheep horn 380mg, Borneolum 380mg, white brick 280mg, and garlic 280mg.
Extract with 0 ml of a heating circulation type extractor for 2 hours and filter. To this filtrate, 30 g of dextrin was added and dissolved, and 450 mg of beef yellow and 380 mg of musk which had been finely powdered were suspended, and then microcapsules were produced by a spraying method. This product contains 30% by weight of ethanol, and 6.6 g corresponds to one whole circle.

【0016】実施例2 実施例1の23種の生薬を粉砕して合わせ、50%(v
/v)エタノール100mlで10日間冷沈して濾過し
た後、濾過物を再び50%(v/v)エタノール100
mlで10日間冷沈濾過して、この二つの濾過物を合わ
せた。この濾液にデキストリン50gを入れて溶かし、
予め微細粉末化した牛黄450mg及び麝香380mg
を懸濁した後、噴霧法でマイクロカプセルを製造する。
この製品はエタノールを約35重量%含有し9.3gが
1丸該当量である。
Example 2 The 23 kinds of crude drugs of Example 1 were crushed and combined to obtain 50% (v
/ V) After being cold-precipitated with 100 ml of ethanol for 10 days and filtered, the filtrate was again filtered with 50% (v / v) ethanol 100.
The two filtrates were combined by cold precipitation filtration in ml for 10 days. Add 50 g of dextrin to the filtrate and dissolve,
Finely powdered beef yellow 450 mg and musk 380 mg
After suspending, the microcapsules are manufactured by a spraying method.
This product contains about 35% by weight of ethanol, and 9.3 g corresponds to one whole circle.

【0017】実施例3 実施例1の25種の生薬を微細粉末化して10%(v/
v)エタノール100mlに分散させて作った懸濁液に
デキストリン10g、ラウリル硫酸ナトリウム0.4g
及び白糖2.0gを入れて溶かした後、噴霧法でマイク
ロカプセルを製造する。この製品はエタノールを約2重
量%未満含有し、3.0gが1丸該当量である。
Example 3 Twenty-five crude drugs of Example 1 were finely powdered to 10% (v /
v) 10 g of dextrin and 0.4 g of sodium lauryl sulfate in a suspension prepared by dispersing in 100 ml of ethanol.
Then, 2.0 g of sucrose is added and dissolved, and then microcapsules are manufactured by a spraying method. This product contains less than about 2% by weight of ethanol, and 3.0 g corresponds to one whole circle.

【0018】実施例4 実施例1の25種の生薬中牛黄と麝香を除いた23種の
生薬を粉砕して合わせた後、水100mlで加熱循環式
抽出器で2時間抽出濾過する。この濾液にカルボキシル
メチルセルロースナトリウム0.5gを溶かし、予めデ
キストリン30gを溶かしたエタノール30mlを添加
して予め微細粉末化した牛黄450mg及び麝香380
mgを懸濁した後噴霧式でマイクロカプセルを製造す
る。この製品はエタノールを約30重量%含有し、7.
4gが1丸該当量である。
EXAMPLE 4 Twenty-three kinds of crude drugs in Example 1 except ginseng and 23 kinds of crude drugs except for musk were crushed and combined, and then extracted and filtered with 100 ml of water for 2 hours by a heating circulation type extractor. To this filtrate, 0.5 g of sodium carboxymethyl cellulose was dissolved, and 30 ml of ethanol in which 30 g of dextrin was dissolved in advance was added to obtain 450 mg of beef yellow powder and musk 380 which were finely powdered in advance.
After suspending mg, microcapsules are manufactured by a spray method. This product contains approximately 30% by weight of ethanol, 7.
4 g corresponds to one round.

【0019】実施例5 実施例1の25種の生薬中牛黄と麝香を除いた23種の
生薬を粉砕して合わせた後、50%(v/v)エタノー
ル100mlで加熱循環式抽出器で2時間抽出濾過す
る。この濾液にデキストリン30gを入れて溶かした液
を用いて噴霧法でマイクロカプセルを製造し、これに予
め微細粉末化した牛黄450mg及び麝香380mgを
添加する。この製品はエタノールを約35重量%含有し
ており、7.0gが1丸該当量である。
Example 5 [0025] Twenty-five herbal medicines of the first example, twenty-three kinds of herbal medicines excluding musk were crushed and combined, and then 50% (v / v) ethanol 100 ml was used to heat a circulating extractor 2 Filter by time extraction. A microcapsule is produced by a spraying method using a solution obtained by adding 30 g of dextrin to the filtrate and dissolving it, and 450 mg of beef yellow and 380 mg of musk which are finely powdered in advance are added thereto. This product contains about 35% by weight of ethanol, and 7.0 g is equivalent to one whole circle.

【0020】実施例6 実施例1の25種の生薬中牛黄、麝香及び龍脳を除いた
22種の生薬を粉砕して合わせた後、30%(v/v)
エタノール100mlで加熱循環式抽出器で2時間抽出
濾過する。この濾液に龍脳380mg及びデキストリン
20g及びゼラチン0.3gを入れて溶かし、予め微細
粉末化した牛黄450mg及び麝香380mgを懸濁し
た後、噴霧法でマイクロカプセルを製造する。この製品
はエタノールを約5重量%含有しており、4.7gが1
丸該当量である。
Example 6 Twenty-two kinds of crude drugs of Example 1 except for Gyu-Yo, Musk and Borneolum were crushed and combined to obtain 30% (v / v).
Extract and filter with 100 ml of ethanol for 2 hours with a heating circulation type extractor. To this filtrate, 380 mg of Borneolum, 20 g of dextrin and 0.3 g of gelatin are put and dissolved, and 450 mg of beef yellow and 380 mg of musk which have been finely powdered in advance are suspended, and then microcapsules are produced by a spraying method. This product contains about 5% by weight of ethanol, and 4.7 g is 1
It is the corresponding amount.

【0021】実施例7 実施例1の25種の生薬中牛黄、麝香及び龍脳を除いた
22種の生薬を粉砕して合わせた後、25%(v/v)
エタノール100mlで加熱循環式抽出器で2時間抽出
濾過する。この濾液に龍脳380mg、デキストリン1
5g、二酸化珪素0.02g及びラウリル硫酸ナトリウ
ム0.4gを入れて溶かし、予め微細粉末化した牛黄4
50mg及び麝香380mgを懸濁した後、噴霧法でマ
イクロカプセルを製造する。この製品はエタノールを約
2重量%含有しており、4.2gが1丸該当量である。
Example 7 25 kinds of crude drugs of Example 1 22 kinds of crude drugs except beef yellow, musk and camphor were ground and combined, and then 25% (v / v)
Extract and filter with 100 ml of ethanol for 2 hours with a heating circulation type extractor. 380 mg of Borneolum and 1 of dextrin were added to this filtrate.
5g, 0.02g of silicon dioxide and 0.4g of sodium lauryl sulfate were added and dissolved, and beef powder 4 was finely powdered in advance.
After suspending 50 mg and 380 mg of musk, microcapsules are produced by a spraying method. This product contains about 2% by weight of ethanol, and 4.2 g corresponds to one whole circle.

【0022】実施例8 実施例7で製造したマイクロカプセル(400mg)を
タルク(約4mg)のような滑沢剤を加えてカプセルに
充填する。
Example 8 The microcapsules (400 mg) prepared in Example 7 are filled with a lubricant such as talc (about 4 mg) to fill the capsules.

【0023】実施例9 実施例7で製造したマイクロカプセル(800mg)を
ステアリン酸マグネシウム(約6mg)のような添加剤
を加えて打錠して錠剤に造る。
Example 9 The microcapsules (800 mg) prepared in Example 7 are tableted by adding an additive such as magnesium stearate (about 6 mg) into tablets.

【0024】実施例10 実施例7で製造したマイクロカプセル(4.2g)をタ
ルク(0.04g)のような添加剤を加えて袋に充填す
る。
Example 10 The microcapsules (4.2 g) prepared in Example 7 are filled in a bag by adding an additive such as talc (0.04 g).

【0025】実施例11 実施例7で製造したマイクロカプセル(4.2g)をス
テアリン酸マグネシウム(0.04g)のような添加剤
を加えて壜充填する。
Example 11 The microcapsules prepared in Example 7 (4.2 g) are bottled with an additive such as magnesium stearate (0.04 g).

【0026】実験例1 :牛黄清心マイクロカプセルの経時変化に伴う安定性実
験 1)実験方法:実施例11で試製品を室温で2年、UV
1amp−45度、45度及び37度−RH75%で
6カ月、60度で2カ月間各々保管して性状、味、溶解
度及び含量を実験した。性状は肉眼で、味は吟味で、溶
解度は精製水及び1液(大韓民国薬典)50mgで1丸
該当量の製品が、何分内に分散溶解されるかで実験し、
含量試験は保健院告示第90−42号(90.6.5,
大韓民国公定書)に従って牛黄定量では結合型ビリルビ
ンで、黄ごん定量ではバイカリンで、龍脳ではイソボル
ネオル及びノルボルネオルで各々定量した。 2)実験結果:表1のように牛黄清心マイクロカプセル
は光、湿度及び温度にあまり影響を受けず室温で2年間
安定である。
Experimental Example 1: Stability experiment with time-dependent change of beef yellow cypress heart microcapsules 1) Experimental method: The trial product of Example 11 was stored at room temperature for 2 years under UV irradiation.
1 amp-45 degrees, 45 degrees and 37 degrees-RH 75% was stored for 6 months and 60 degrees for 2 months, and the properties, taste, solubility and content were tested. The appearance is macroscopic, the taste is scrutinized, and the solubility is purified water and 50 mg of 1 liquid (Korean drug).
The content test was conducted by the Public Health Center Notification No. 90-42 (90.6.5.
According to the Korean National Standards), bovine yellow quantitation was determined with bound bilirubin, yellow quantitation with baicalin, and Borneolum with isoborneol and norborneol. 2) Experimental results: As shown in Table 1, beef yellow Qingshin microcapsules are not affected by light, humidity and temperature and are stable at room temperature for 2 years.

【0027】[0027]

【表1】 [Table 1]

【0028】[0028]

【発明の効果】本発明の牛黄清心丸マイクロカプセル
は、携帯及び服用が便利で特に生薬抽出物の強い味が隠
蔽されて服用し易く、極めて迅速に薬効が現れる新しい
製剤であり、また本発明の方法は、このマイクロカプセ
ルを迅速に大量生産するのに適している。
INDUSTRIAL APPLICABILITY The beef yellow cypress round microcapsule of the present invention is a new preparation which is convenient to carry and to take, in particular, the strong taste of the crude drug extract is masked and is easy to take, and the drug effect is exhibited very quickly. Method is suitable for rapid mass production of these microcapsules.

Claims (11)

【特許請求の範囲】[Claims] 【請求項1】 山薬、甘草、人参、蒲黄、神曲、大豆皇
巻、桂皮、阿膠、芍薬、麦門冬、黄ごん、当帰、防風、
白朮、柴胡、桔梗、杏仁、茯苓、川きゅう、牛黄、羚羊
角、麝香、龍脳、白れん、及び乾薑を微細粉末化して水
及びアルコールに沈出して得た液に被膜物質を加えて溶
解させ、通常の添加剤を加えないか又は通常の添加剤を
加えて噴霧乾燥して得られた牛黄清心マイクロカプセ
ル。
1. Mountain herbs, licorice, carrots, ginger yellow, Shinkyoku, soybean roll, cinnamon skin, Ag, peony, barley winter, yellow rice, toki, windbreak,
White powder, saiko, bellflower, apricot kernel, 苯 苓, river cucumber, beef yellow, ginseng horn, musk, borneol, white brick, and licorice are finely pulverized and added to water and alcohol. Beef yellowish heart microcapsules obtained by spray-drying by dissolving and dissolving with usual additives or adding usual additives.
【請求項2】 デキストリン、アラビアゴム、ゼラチ
ン、可溶性澱粉、アルギン酸ナトリウム、トラガカンタ
ゴム、ザンタンゴム及びグアゴム等の被膜物質中から選
択された1種以上の被膜物質を加えて溶解させ、そのま
ま噴霧乾燥させるか又は界面活性剤、溶解補助剤、香味
剤、安定化剤及び懸濁剤等から選択された通常の添加剤
を加え噴霧乾燥して得られた請求項1記載の牛黄清心マ
イクロカプセル。
2. One or more coating substances selected from coating substances such as dextrin, gum arabic, gelatin, soluble starch, sodium alginate, tragacanta gum, xanthan gum and guar gum are added and dissolved, and spray-dried as it is or The beef yellow cypress heart microcapsule according to claim 1, obtained by spray-drying a conventional additive selected from a surfactant, a solubilizing agent, a flavoring agent, a stabilizer, a suspending agent and the like.
【請求項3】 山薬、甘草、人参、蒲黄、神曲、大豆皇
巻、桂皮、阿膠、芍薬、麦門冬、黄ごん、当帰、防風、
白朮、柴胡、桔梗、杏仁、茯苓、川きゅう、牛黄、羚羊
角、麝香、龍脳、白れん、及び乾薑を微細粉末化して水
及びアルコールに沈出して得た液に被膜物質を加えて溶
解させ、通常の添加剤を加えないか又は通常の添加物を
加えて噴霧乾燥することを特徴とする牛黄清心マイクロ
カプセルの製造方法。
3. Mountain herb, licorice, carrot, ginger yellow, sacred song, soybean roll, cinnamon skin, Ag, peony, barley winter, yellow rice, toki, windbreak,
White powder, saiko, bellflower, apricot kernel, 苯 苓, river cucumber, beef yellow, ginseng horn, musk, borneol, white brick, and licorice are finely pulverized and added to water and alcohol. A method for producing microcapsules of beef yellow quince, which is characterized in that the microcapsules are dissolved by spraying and dried by spraying with or without addition of usual additives.
【請求項4】 デキストリン、アラビアゴム、ゼラチ
ン、可溶性澱粉、アルギン酸ナトリウム、トラガカンタ
ゴム、ザンタンゴム及びグアゴム等の被膜物質中から選
択された1種以上の被膜物質を加えて溶解させ、そのま
ま噴霧乾燥させるか又は界面活性剤、溶解補助剤、香味
剤、安定化剤及び懸濁剤等から選択された通常の添加剤
を更に加えて噴霧乾燥させる請求項3記載の牛黄清心マ
イクロカプセルの製造方法。
4. One or more coating substances selected from coating substances such as dextrin, gum arabic, gelatin, soluble starch, sodium alginate, tragacanta gum, xanthan gum and guar gum are added and dissolved, and spray-dried as it is or The method for producing beef yellow Qingshin microcapsules according to claim 3, wherein usual additives selected from surfactants, solubilizers, flavors, stabilizers, suspending agents and the like are further added and spray-dried.
【請求項5】 山薬、甘草、人参、蒲黄、神曲、大豆皇
巻、桂皮、阿膠、芍薬、麦門冬、黄ごん、当帰、防風、
白朮、柴胡、桔梗、杏仁、茯苓、川きゅう、牛黄、羚羊
角、麝香、龍脳、白れん、及び乾薑から選択された一部
の生薬を微細粉末化して水及びアルコールに沈出して得
た液に残りの生薬を微細粉末化して加え、被膜物質を加
えて溶解させ、通常の添加剤を加えないか又は通常の添
加剤を加えて噴霧乾燥して得られた牛黄清心マイクロカ
プセル。
5. Mountain herbs, licorice, carrots, ginger yellow, sacred songs, soybean rolls, cinnamon skin, Ag, peony, barley winter, yellow rice, toki, windbreak,
Fine powder of some crude drugs selected from Shirasu, Saiko, Kikyo, Apricot kernels, 苯 苓, Kawakyu, Beef yellow, yan mutton, musk, dragon brain, white brick, and kangaraku Microbeads obtained from the obtained liquid by finely powdering the rest of the herbal medicine, adding a coating substance to dissolve it, and adding no usual additives or adding ordinary additives and spray-drying.
【請求項6】 デキストリン、アラビアゴム、ゼラチ
ン、可溶性澱粉、アルギン酸ナトリウム、トラガカンタ
ゴム、ザンタンゴム及びグアゴム等の被膜物質中から選
択された1種以上の被膜物質を加えて溶解させ、噴霧乾
燥させるか又は界面活性剤、溶解補助剤、香味剤、安定
化剤及び懸濁剤等から選択された添加剤を更に加え噴霧
乾燥させて製造した請求項5記載の牛黄清心マイクロカ
プセル。
6. One or more coating substances selected from coating substances such as dextrin, gum arabic, gelatin, soluble starch, sodium alginate, tragacanta gum, xanthan gum and guar gum are added and dissolved, and then spray-dried or an interface. The beef yellow Qingshin microcapsule according to claim 5, which is produced by further adding an additive selected from an activator, a solubilizing agent, a flavoring agent, a stabilizer, a suspending agent and the like, and spray-drying.
【請求項7】 山薬、甘草、人参、蒲黄、神曲、大豆皇
巻、桂皮、阿膠、芍薬、麦門冬、黄ごん、当帰、防風、
白朮、柴胡、桔梗、杏仁、茯苓、川きゅう、牛黄、羚羊
角、麝香、龍脳、白れん、及び乾薑から選択された一部
の生薬を微細粉末化して水及びアルコールに沈出して得
た液に残りの生薬を微細粉末化して加え、被膜物質を加
えて溶解させ、通常の添加剤を加えないか又は通常の添
加剤を加えて噴霧乾燥させることを特徴とする牛黄清心
マイクロカプセルの製造方法。
7. Mountain herbs, licorice, carrots, ginger yellows, Shinkyoku, soybean rolls, cinnamon, Ag, peony, barley winter, yellow rice, toki, windbreak,
Fine powder of some crude drugs selected from Shirasu, Saiko, Kikyo, Apricot kernels, 苯 苓, Kawakyu, Beef yellow, yan mutton, musk, dragon brain, white brick, and kangaraku The remaining herbal medicines are finely pulverized and added to the obtained liquid, and a coating substance is added and dissolved therein, and ordinary additives are not added or ordinary additives are added and spray-dried. Manufacturing method.
【請求項8】 デキストリン、アラビアゴム、ゼラチ
ン、可溶性澱粉、アルギン酸ナトリウム、トラガカンタ
ゴム、ザンタンゴム及びグアゴム等の被膜物質中から選
択された1種以上の被膜物質を加えて溶解させ、噴霧乾
燥させるか又は、界面活性剤、溶解補助剤、香味剤、安
定化剤及び懸濁剤等から選択された添加剤を加え噴霧乾
燥させる請求項7記載の牛黄清心マイクロカプセルの製
造方法。
8. One or more coating substances selected from coating substances such as dextrin, gum arabic, gelatin, soluble starch, sodium alginate, tragacanta gum, zantane gum and guar gum are added and dissolved, and then spray-dried, or 8. The method for producing beef yellow Qingshin microcapsules according to claim 7, wherein an additive selected from a surfactant, a solubilizing agent, a flavoring agent, a stabilizer, a suspending agent and the like is added and spray-dried.
【請求項9】 山薬、甘草、人参、蒲黄、神曲、大豆皇
巻、桂皮、阿膠、芍薬、麦門冬、黄ごん、当帰、防風、
白朮、柴胡、桔梗、杏仁、茯苓、川きゅう、牛黄、羚羊
角、麝香、龍脳、白れん、及び乾薑から選択された一部
の生薬を微細粉末化して水及びアルコールに沈出して得
た液に被膜物質を加えて溶解させ、通常の添加剤を加え
ないか又は通常の添加剤を加え噴霧乾燥して得られたマ
イクロカプセルに残りの生薬を微細粉末化して添加した
牛黄清心マイクロカプセル。
9. Mountain herbs, licorice, carrots, ginger yellow, sacred songs, soybean rolls, cinnamon skin, Ag, peony, barley winter, yellow dust, toki, windbreak,
Fine powder of some crude drugs selected from Shirasu, Saiko, Kikyo, Apricot kernels, 苯 苓, Kawakyu, Beef yellow, yan mutton, musk, dragon brain, white brick, and kangaraku Beef yellow Seishin micro was prepared by adding the coating substance to the obtained liquid and dissolving it, and adding the usual crude drug to the microcapsules obtained by spray-drying with or without adding the usual additives. capsule.
【請求項10】 デキストリン、アラビアゴム、ゼラチ
ン、可溶性澱粉、アルギン酸ナトリウム、トラガカンタ
ゴム、ザンタンゴム及びグアゴム等から選択された1種
以上の被膜物質を加えて溶解させ、噴霧乾燥させるか又
は、界面活性剤、溶解補助剤、香味剤、安定化剤及び懸
濁剤等から選択された通常の添加剤を加え噴霧乾燥させ
たマイクロカプセルに残りの生薬を微細粉末化して添加
した請求項9記載の牛黄清心マイクロカプセル。
10. A coating substance of at least one selected from dextrin, gum arabic, gelatin, soluble starch, sodium alginate, tragacanta gum, zantane gum, guar gum, etc. is added, dissolved and spray-dried, or a surfactant, The microbeads of Gyuhuang Qingshin according to claim 9, wherein the rest of the crude drug is finely powdered and added to microcapsules obtained by adding usual additives selected from a solubilizing agent, a flavoring agent, a stabilizer, a suspending agent, etc. and spray-drying. capsule.
【請求項11】 請求項1、2、5、6、9又は10記
載の牛黄清心マイクロカプセルを通常の薬剤学的に使用
される賦形剤を加え通常の薬剤学的方法で錠剤、カプセ
ル剤及び細粒剤の剤形に製造した牛黄清心マイクロカプ
セルの錠剤、カプセル又は細粒剤。
11. Tablets and capsules prepared by adding the excipients conventionally used in pharmaceutically to the microcapsules of Huangjing Qingshin according to any one of claims 1, 2, 5, 6, 9 or 10 by a conventional pharmaceutical method. And a tablet, capsule or fine granule of beef huangshinshin microcapsule manufactured in the form of fine granule.
JP5112347A 1992-04-17 1993-04-16 Oriental bezoar microcapsule and preparation thereof Pending JPH06107555A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019920006424A KR930021196A (en) 1992-04-17 Uhwang Cheongsim microcapsules and its manufacturing method
KR92-6424 1992-04-17

Publications (1)

Publication Number Publication Date
JPH06107555A true JPH06107555A (en) 1994-04-19

Family

ID=19331913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5112347A Pending JPH06107555A (en) 1992-04-17 1993-04-16 Oriental bezoar microcapsule and preparation thereof

Country Status (2)

Country Link
JP (1) JPH06107555A (en)
CN (1) CN1082421A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042350A1 (en) * 1997-03-21 1998-10-01 Cheil Jedang Corporation Cholesterol lowering pharmaceutical composition
JP2001181192A (en) * 1999-12-24 2001-07-03 Alps Yakuhin Kogyo Kk Moisture-proof galenical extract
WO2001091769A3 (en) * 2000-06-01 2002-09-12 Theralife Inc Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
EP1358887A1 (en) * 2002-04-29 2003-11-05 BrainGenesis Biotechnology Co., Ltd. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
US6872409B2 (en) 2001-10-17 2005-03-29 Braingenesis Biotechnology Co., Ltd. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
EP1602364A1 (en) * 2004-05-25 2005-12-07 Cognis IP Management GmbH Microcapsules (XXX) comprising plant extracts and process for their preparation
EP1067913A4 (en) * 1998-04-01 2009-03-11 Bioresponse Llc Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
US20090280200A1 (en) * 2008-05-08 2009-11-12 Industrial Technology Research Institute Herbal extracts which induce immune cells to produce interferon and activate toll-like receptors
CN103432275A (en) * 2013-08-30 2013-12-11 贵阳新天药业股份有限公司 Sustained-release nano-capsules for improving endometrial receptivity and application thereof
CN104758512A (en) * 2015-04-28 2015-07-08 莫凯音 Chinese herb tea for preventing and curing convulsion and twitch
JP2016164147A (en) * 2015-02-26 2016-09-08 大正製薬株式会社 Extract powder

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046192C (en) * 1994-03-30 1999-11-10 赵友苓 Method for prodn. of deodorized fish oil microcapsule

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042350A1 (en) * 1997-03-21 1998-10-01 Cheil Jedang Corporation Cholesterol lowering pharmaceutical composition
EP1067913A4 (en) * 1998-04-01 2009-03-11 Bioresponse Llc Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
JP2001181192A (en) * 1999-12-24 2001-07-03 Alps Yakuhin Kogyo Kk Moisture-proof galenical extract
WO2001091769A3 (en) * 2000-06-01 2002-09-12 Theralife Inc Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
US6872409B2 (en) 2001-10-17 2005-03-29 Braingenesis Biotechnology Co., Ltd. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
US6936282B2 (en) 2001-10-17 2005-08-30 Braingenesis Biotechnology Co., Ltd. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
EP1358887A1 (en) * 2002-04-29 2003-11-05 BrainGenesis Biotechnology Co., Ltd. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
EP1602364A1 (en) * 2004-05-25 2005-12-07 Cognis IP Management GmbH Microcapsules (XXX) comprising plant extracts and process for their preparation
US20090280200A1 (en) * 2008-05-08 2009-11-12 Industrial Technology Research Institute Herbal extracts which induce immune cells to produce interferon and activate toll-like receptors
CN103432275A (en) * 2013-08-30 2013-12-11 贵阳新天药业股份有限公司 Sustained-release nano-capsules for improving endometrial receptivity and application thereof
JP2016164147A (en) * 2015-02-26 2016-09-08 大正製薬株式会社 Extract powder
CN104758512A (en) * 2015-04-28 2015-07-08 莫凯音 Chinese herb tea for preventing and curing convulsion and twitch

Also Published As

Publication number Publication date
CN1082421A (en) 1994-02-23

Similar Documents

Publication Publication Date Title
JP2820239B2 (en) Controlled release powder and its production
JP2002538112A (en) Oral drug delivery system
JPH06107555A (en) Oriental bezoar microcapsule and preparation thereof
JPH0460968B2 (en)
WO2006099783A1 (en) A pharmaceutical composition for treating depression and method for preparation thereof
CN106511260B (en) A kind of Berberine hydrochloride takes orally pellet xerogel and its preparation method and application
US4771077A (en) Spray dried acetaminophen
CN101239044B (en) Solid composition
CN103083284B (en) Film preparation and its preparation method
CN101686944A (en) The high dose composition of ursodesoxycholic acid
CN101244044A (en) Entecavir dispersible tablet and preparation thereof
JP3269131B2 (en) Method for producing Chinese herbal hard capsules
CN101301318A (en) Ginkgo leaf extract oral freeze-dried slices and preparation thereof
RU2563190C2 (en) Medication based on dry extracts of medicinal plants and method of obtaining thereof (versions)
JPH07324039A (en) Agent for promoting production of nitrogen monoxide
Jacob et al. Preparation and evaluation of microencapsulated fast melt tablets of ambroxol hydrochloride
CN111617042A (en) Composite calcium carbonate vitamin D3Water-free swallow granule and preparation method thereof
PT85880B (en) BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for the preparation of delayed-acting pharmaceutical compositions comprising as carrier substance a mixture of microcrystalline cellulose with hydroxypropyl methylcellulose
JP4400941B2 (en) Kampo-containing tablets, Kampo-filled capsules, herbal medicine-containing tablets, herbal medicine-filled capsules, manufacturing method of Kampo-containing tablets, herbal medicine-containing capsules, herbal medicine-containing tablets, and herbal medicine-filled capsules
CN102038642A (en) Ginkgolide B solid dispersoid and preparation method thereof
US20130216594A1 (en) Preparation of orodispersible films
CN101301350A (en) Lamioplomis rotate extract oral freeze-dried tablet and preparation thereof
Nasreen et al. Mouth dissolving tablets-A unique dosage form curtailed for special purpose: a review
CN105919982A (en) Racecadotril oral fast dissolving film and preparation method thereof
KR100646446B1 (en) Film type medicine of nanocapsulted physiological activator and method for manufacturing the same